<style face="normal" font="default" size="100%">40 Novel biomarker assays for detecting labyrinthin-positive adenocarcinomas for a phase I/II trial of peptide vaccine LabVax 3(22)-23 alone or in combination with pembrolizumab</style>

Drupal-HighWire